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Background: To evaluate the role of integrated backscatter intravascular ultrasound (IB-IVUS) in assessing
the morphology of neointima in bare-metal stent (BMS) and drug-eluting stent (DES) restenosis as
compared to the gold-standard, optical coherence tomography (OCT).
Methods: A total of 120 cross-sections were evaluated by IB-IVUS and OCT at ﬁve cross-sections from 24
patients (24 lesions): at theminimal lumen area (MLA) and at 1 and 2mmproximal and distal to theMLA
site in 24 lesions (9 treated with DES and 15 treated with BMS). IB-IVUS and OCT ﬁndings were analyzed
according to the time at which restenosis was identiﬁed (early <12 months and late ≥12 months) and
the stent type.
Results: IB-IVUSwas found tocorrectly characterize theneointimaofbothBMSandDES in-stent restenosis
(ISR) as compared to OCT. The overall agreement between the pattern of ISR neointima by IB-IVUS and
that by OCT was excellent (kappa=0.85, 95% CI 0.76–0.94). Late DES ISR was characterized by more non-
homogeneous, low backscatter and lipid-laden neointima, as compared to the BMS equivalent (BMS vs.
DES, 45.0% vs. 80.0%, p<0.01; 51.7% vs. 85.0%, p=0.008; 33.3% vs. 65.0%, p<0.01, respectively).
Conclusions: IB-IVUS assessment of the ISR neointima pattern appears to provide similar information as
the gold-standard OCT in patients with stable angina. Both modalities suggested that late DES restenosis
is characterized by a non-homogeneous lipid-laden neointima.
© 2014 Japanese College of Cardiology. Published by Elsevier Ltd. All rights reserved.ntroduction
Optical coherence tomography (OCT) and integrated backscat-
er intravascular ultrasound (IB-IVUS) can provide excellent tissue
haracterization of coronary plaque morphology [1,2]. In vivo OCT
mages can provide more detailed structural information of coro-
ary atherosclerotic plaques as compared to conventional intravas-
ular ultrasound (IVUS). Previous studies have demonstrated
∗ Corresponding author at: EMO-GVM Centro Cuore Columbus, 48 Via M.
uonarroti, 20145 Milan, Italy. Tel.: +39 02 4812920; fax: +39 02 48193433.
E-mail address: katsumasaz4@yahoo.co.jp (K. Sato).
ttp://dx.doi.org/10.1016/j.jjcc.2014.03.007
914-5087/© 2014 Japanese College of Cardiology. Published by Elsevier Ltd. All rights rethat the OCT ﬁndings regarding atherosclerotic plaque composi-
tion correlate well with those obtained from histological samples
[2]. Attempts to characterize the coronary atherosclerotic plaque
composition have also been made with other modalities including
IB-IVUS [3,4]. A prior OCT study by our group has demonstrated
that the differences in the neointima exist at different restenotic
phases and between different stent types [5,6]. However, quanti-
tative evaluation of the neointima morphology at early and late
restenosis and according to stent type [bare-metal stent (BMS) vs.
drug-eluting stent (DES)] has not been well characterized by IB-
IVUS. The purpose of this study was to examine the role of IB-IVUS
in characterizing the neointima of in-stent restenotic (ISR) seg-
ments according to the time at which the restenosis was identiﬁed
served.
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early <12months or late phase≥12months) and the stent type and
ompare theseﬁndings to thoseobtainedby thegold-standardOCT.
ethods
tudy patients
The study population was recruited from a total of 194 patients
ith stable angina who were admitted to Fukuyama Cardiovascu-
ar Hospital from June 2009 to November 2011 for target lesion
evascularization (TLR). Among them, 24 consecutive patients who
ubsequently underwent TLR using both IB-IVUS and OCT were
nrolled in this study. All patients had ischemic symptoms or
vidence of myocardial ischemia in the presence of ≥75% diam-
ter stenosis at follow-up angiography. We excluded patients
ith acute coronary syndromenecessitatingprimarypercutaneous
ntervention and stent edge restenosis. The study protocol was
pproved by the institutional ethics committee of Fukuyama Car-
iovascular Hospital, and written consent was obtained from all
atients prior to the procedure.ray-scale IVUS and IB-IVUS measurements
IB-IVUS and gray-scale IVUS examinations for ISR lesions were
erformed before any intervention and after the intracoronary
ig. 1. Gray scale and integrated backscatter intravascular ultrasound (IB-IVUS) and o
estenosis (ISR). (A) Neointima (A3) was deﬁned as the area between the lumen border
B-IVUS analysis: ﬁbrous area (green), lipid area (blue), mixed area (yellow), and calciﬁ
roups: homogeneous pattern (B1) and non-homogeneous pattern (B2 and B3) according
attern of neointima tissue component was classiﬁed into two groups: homogeneous pa
istribution. Both the (B) and (C) images were obtained at the same cross-section. (For int
he web version of this article.)logy 64 (2014) 488–495 489
administrationof isosorbidedinitrate (1–2mg). The transducerwas
advanced into the distal reference segment, and an imaging run
was performed back through the stent to coronary ostium using a
motorized transducer pullback (0.5mm/s) system.
Gray-scale IVUS and ultrasound signals were acquired with a
commercially available IVUS imaging system (VISIWAVE, Terumo,
Tokyo, Japan) using a 43-MHz mechanically rotating IVUS catheter
(View IT, Terumo). During the pullback, images were obtained
at 30 frames/s. All IVUS imaging data were stored in the con-
sole. For ofﬂine analysis, digital copies of the IVUS images were
saved on a CD-ROM. The data were quantitatively analyzed by two
independent observerswith two off-line computer-based software
systems (VISIATLAS, Terumo). Tissue characterization of neointi-
mal composition was achieved on IB-IVUS using VISIATLASTM. The
excellent correlation of IB-IVUS and histology has been reported
previously [7–11]. After tracing vessel area, lumen area, and stent
area, grayscale IVUS images and IB-IVUS color-coded maps were
displayed side-by-side on a monitor. A neointima was deﬁned as
the area between the lumen border and the inner border of the
stent struts to avoid stent strut artifacts (Fig. 1A3). The imageswere
analyzed by two observers who were blinded to the clinical and
procedural characteristics. We applied the manufacturer’s default
settings on the basis of previous data [9,10,12] to deﬁne a range of
IB values for neointimal tissue components. According to the sig-
nal level, the IB-IVUS analysis classiﬁed the color-coded tissue into
ptical coherence tomography (OCT) of in-stent neointima at the area of in-stent
and the inner border of the stent struts (asterisk) to avoid stent strut artifacts. (B)
cation (red). The pattern of neointima tissue component was classiﬁed into two
to neointima lipid distribution. (C) Pattern of ISR neointima as assessed by OCT. The
ttern (C1) and non-homogeneous pattern (C2 and C3) according to neointima lipid
erpretation of the references to color in this ﬁgure legend, the reader is referred to
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our major components: red (calciﬁcation), yellow (dense ﬁbro-
is), green (ﬁbrosis), and blue (lipid). Each component of neointima
issue was represented as a percentage of measured total neoin-
ima and the pattern of neointima was classiﬁed into two groups
ccording to the difference of lipid distribution in the neointima:
1) homogeneous neointima, characterized by the absence of a lipid
ool and a layered structure (Fig. 1B1) and (2) non-homogeneous
eointima which is further subdivided into two patterns: (a) het-
rogeneous neointima characterized by the presence of a lipid pool
Fig. 1B2) and (b) layered neointima with mainly ﬁbrous tissue on
he surface and mainly lipid tissue at the bottom but no lipid pool
Fig. 1B3). IB-IVUS-derived thin cap ﬁbroatheroma (IB-IVUS TCFA)
as deﬁned as a plaque with percentage lipid pool area ≥55% as
reviously described [13].
CT measurements
After performing the IB-IVUS analysis, OCT images were
btained (LightLab Imaging Inc., Westford, MA, USA). A 0.016 in.
ire-type imaging catheter (ImagingWire; LightLab Imaging Inc.)
as advanced to the distal end of the stent through a 4Fr over-
he-wire occlusion balloon catheter (HeliosTM; LightLab Imaging).
he occlusion balloon was then inﬂated to 0.3 atm, while lactated
inger’s solution was infused from the balloon tip at 0.5ml/s to
ush the blood from the imaging ﬁeld. The entire stent was imaged
ith an automatic pullback device moving at 1.5mm/s. The OCT
easurements were performed at the cross-sections determined
y IVUS. The identical cross-sections were carefully selected with
he use of intravascular and perivascular landmarks and a constant
ullback speed as previously reported [14].
TheOCT pattern of neointimawas classiﬁed into two groups: (1)
omogeneouspattern (Fig. 1C1) and (2)non-homogeneouspattern,
hich further included two distinctive patterns (a) heterogeneous
attern (Fig. 1C2) and (b) layered pattern (Fig. 1C3). This classi-
cation has been described in detail elsewhere [14]. To describe
he morphologic appearance of the neointima further, restenotic
issue backscatter, lumen shape, intra-luminal material, and the
resence of microvessels were also analyzed for each slice in the
SR lesions (Fig. 2). The imageswere analyzedby twoobserverswho
ere blinded to the clinical and procedural characteristics. Using
he already validated criteria for plaque characterization [2], the
ig. 2. Qualitative optical coherence tomography (OCT) assessment of in-stent resteno
ere deﬁned as follows: high restenotic tissue backscatter (A-1) or low restenotic tissue
aden neointima containing (C), visible microvessels (D), thin-cap ﬁbroatheroma (TCFA)
icrovessels. Yellow arrows indicate TCFA. TCFA was deﬁned as a plaque with a ﬁbrou
upture surrounded by TCFA-like neointima. (For interpretation of the references to colorlogy 64 (2014) 488–495
minimum ﬁbrous cap thickness was measured at its thinnest part.
OCT-derived TCFA was deﬁned as a plaque with a ﬁbrous cap of
<65m according to previous reports [15]. If the ﬁbrous cap of a
given plaque was visible, the thickness of the cap was measured
ﬁve times and the average of the three middle values was calcu-
lated. Calciﬁcation was deﬁned as a well-delineated, signal-poor
mass with a sharp border [16,17].
IB-IVUS-OCT ﬁndings co-registration and analysis
OCT slices of theminimal stent area (MSA) corresponding to the
MSA obtained from IB-IVUSwere selected for analysis. IB-IVUS and
OCT images were acquired at ﬁve cross-sections: at the minimal
lumen area site and at 1 and 2mm proximal and distal to the MSA
site. Each slice proximal anddistal to theMSA site obtainedwith IB-
IVUS and OCT was selected per 1mm by using the pullback speed
and frame numbers. Moreover, in order to obtain corresponding
images of IB-IVUS and OCT, the distances from at least two land-
marks, suchas sidebranches and/or calciﬁcations,were alsousedas
references. Thus each slice was matched between IB-IVUS and OCT
precisely. A total of 120 cross-sections including40early restenoses
cross-sections (identiﬁed at <12 months) and 80 late restenoses
cross-sections (identiﬁed at ≥12 months) of either BMS (n=15, 75
cross-sections) or DES (n=9, 45 cross-sections) were evaluated in
this study.
Statistical analysis
All values are expressed as mean± SD (continuous variables)
or as absolute numbers and percentages (categorical variables).
Continuous variables were compared with the unpaired t-test.
Categorical variables were compared with chi-square statistics or
Fisher’s exact test. All p-values are two-sided, and p-values <0.05
were considered statistically signiﬁcant. The agreement between
the pattern of ISR neointima by OCT and that by IB-IVUS was
quantiﬁed by Cohen’s kappa test for concordance. A kappa value
of 0.61–0.80 indicates good agreement, and 0.81–1.0 indicates
excellent agreement. A kappa test was also used to assess the
inter-observer and intra-observer variability for qualitative OCT
and IB-IVUS assessments. All statistical analyses were performed
using Statview 5.0 (SAS Institute, Cary, NC, USA).
sis. To evaluate the morphologic appearance of the restenotic tissue, parameters
backscatter (A-2), regular lumen shape (B-1) or irregular lumen shape (B-2), lipid-
(E), intimal rupture/TCFA (F). Asterisks (*) indicate lipid pool. Red arrows indicate
s cap of <65m and lipid content in ≥1 quadrant. White arrow indicates intimal
in this ﬁgure legend, the reader is referred to the web version of this article.)
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Table 1
Baseline characteristics.
BMS group (n=15) DES group (n=9) p-Value
Age, years 68.1±9.9 63.8±8.2 0.29
Male, n (%) 14 (93.3) 9 (100) 0.43
Diabetes mellitus, n (%) 6 (40) 5 (56) 0.46
Hyperlipidemia, n (%) 11 (73) 7 (78) 0.80
Hypertension, n (%) 14 (93.3) 8 (88.9) 0.70
Smoking, n (%) 6 (40) 6 (67) 0.20
Left ventricular ejection fraction, % 59.8±12.0 50.8±11.2 0.08
Previous myocardial infarction, n (%) 10 (66.7) 8 (88.9) 0.22
Previous coronary bypass, n (%) 0 2 (22.2%) 0.06
Follow up duration, mo 69.7±56.2 29.4±25.1 <0.01
Laboratory data
Total cholesterol, mg/dL 167.8±21.2 177.8±39.4 0.43
LDL cholesterol, mg/dL 92.4±20.9 96.0±26.7 0.71
HDL cholesterol, mg/dL 51.5±18.9 42.3±13.1 0.21
TG, mg/dL 117.9±68.1 176.7±85.9 0.08
LDL/HDL cholesterol ratio 2.0±0.8 2.6±1.2 0.21
HemoglobinA1c, % 6.0±0.7 6.3±0.7 0.40
Medications
Ca antagonist 9 (60.0) 4 (44.4) 0.46
-Blocker 11 (73.3) 8 (88.9) 0.36
ACE-I/ARB 12 (80.0) 6 (66.7) 0.47
Statin 12 (80) 8 (88.9) 0.57
Stent information
Stent size, mm 3.5±0.3 2.7±0.3 <0.01
Stent length, mm 21.5±9.4 23.6±4.0 0.54
Types of drug-eluting stent
Sirolimus 5 (56)
Paclitaxel 2 (22)
Everolimus 2 (22)
D
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MS, baremetal stent; DES, drug-eluting stent; LDL, low-density lipoprotein; HDL, hi
RB, angiotensin receptor blockers.
esults
Clinical and procedural characteristics are shown in Table 1. Fif-
een patients had restenosis after BMS implantation, and 9 patients
fter DES implantation (5 patients treated with sirolimus-eluting
tents, 2 patients treated with paclitaxel-eluting stents, and 2
atients treated with everolimus-eluting stents). Patient charac-
eristics were not signiﬁcantly different between the BMS and DES
roups. Overall follow-up duration from stent implantation to ISR
as 53.6±49.1 months, with the follow-up duration in the group
able 2
onventional IVUS and IB-IVUS data (early phase <12 months or late phase ≥12 months)
BMS group (75 cross-sections) DES group
Early (15
cross-
sections)
Late (60
cross-
sections)
p-Value* Early (25
cross-
sections)
Tissue coverage structure
Homogeneous, n (%) 10 (66.7) 37 (61.7) 0.52 9 (36)
Non-homogeneous, n (%) 5 (33.3) 23 (38.3) 16 (64)
Heterogeneous, n (%) 0 10 (16.7) 6 (24)
Layered, n (%) 5 (16.7) 13 (21.7) 10 (40)
Quantitative analysis
Stent area, mm2 7.8±0.6 8.2±2.2 0.42 7.3±1.4
IH area, mm2 5.1±0.7 5.2±1.9 0.74 4.6±1.6
Lumen area, mm2 2.7±0.9 3.0±1.3 0.40 2.6±0.8
Lesion length, mm 12.5±1.6 12.4±3.9 0.95 7.4±2.8
Fibrous neointima, % 65.9±8.1 51.8±12.0 <0.01 65.2±6.5
Lipid neointima, % 28.5±9.7 35.8±14.0 0.06 24.1±10
Mixed neointima, % 4.8±3.2 8.9±6.6 0.02 10.1±7.0
Calciﬁcation, % 0.8±0.9 3.5±3.3 <0.01 0.5±0.3
ata are presented as no. (%) or mean± SD.
B-IVUS, integrated backscatter intravascular ultrasound; BMS, bare metal stent; DES, dru
-Value*: early phase vs. late phase in BMS. p-Value**: early phase vs. late phase in DES. pnsity lipoprotein; TG, triglyceride; ACE-I, angiotensin-converting enzyme inhibitor;
treated with BMS being longer than that in the group treated with
DES (69.7±56.2 months, 29.4±25.1 months, p<0.01). The stent
size was signiﬁcantly greater in the BMS group, with stent length
being similar between the two groups. A total of 120 cross-sections
from the 24 patients who underwent TLR were divided into four
groups according to the time atwhich the restenosis was identiﬁed
(early phase or late phase) and stent type (BMS or DES). The stent
and lumen areas at the each cross-sectionwere signiﬁcantly differ-
ent among the four groups, whereas intimal hyperplasia (IH) area
was similar in each group according to conventional IVUS analysis
.
(45 cross-sections) p-Value† (early
restenosis BMS vs.
DES)
p-Value‡ (late
restenosis
BMS vs. DES)
Late (20
cross-
sections)
p-Value**
4 (20) 0.24 0.06 <0.01
16 (80)
8 (40)
8 (40)
9.8±3.3 0.02 0.18 0.02
5.8±3.3 0.12 0.30 0.33
3.9±1.6 0.01 0.81 0.02
10.1±3.1 0.23 0.03 0.23
54.5±12.7 <0.01 0.76 0.39
.7 37.0±13.9 <0.01 0.21 0.76
7.7±3.8 0.46 <0.01 0.46
0. 9±0.4 <0.01 0.17 <0.01
g-eluting stent; IH area, intimal hyperplasia area.
-Value†: BMS vs. DES in early phase. p-Value‡: BMS vs. DES in late phase.
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Fig. 3. Comparison of the optical coherence tomography-derived microvessels
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Table 2). The length of the ISR lesion in the early DES resteno-
is was signiﬁcantly shorter than that in the BMS early restenosis
7.4±2.8mm vs. 12.5±1.6mm, p=0.03).
issue component ratios in BMS and DES restenotic neointima as
ssessed by IB-IVUS
Considering the pattern of neointima as classiﬁed by IB-IVUS,
ES restenosis was characterized by a non-homogeneous pat-
ern as compared to BMS restenosis, especially in the case of late
estenosis (38.3% vs. 80.0%, p<0.01). Percentage ﬁbrous neointima
n early BMS restenosis was higher than that in late BMS resteno-
is (65.9±8.1% vs. 51.8±12.0%, p<0.01) with a trend toward a
igher percentage of lipid neointima in late restenosis (28.5±9.7%
s. 35.8±14.0%, p=0.06) (Table 2). Percentage lipid neointima in
arly DES restenosis on the other handwas signiﬁcantly lower than
hat in late DES restenosis (24.1±10.7% vs. 37.0±13.9%, p<0.01).
ercentage calciﬁcation in late restenosis was signiﬁcantly greater
han that in early restenosis in both the stent types. Moreover, the
resence of calcium in BMS late restenosis was greater than that
n the DES equivalent (3.5±3.3% vs. 0.9±0.4%, p<0.01). The intra-
bserver and inter-observer agreement for the ISR IB-IVUS pattern
aswithinanacceptable range (intra-observer; kappa=0.96, inter-
bserver; kappa=0.91, respectively).
issue characterization of BMS and DES restenotic neointima as
ssessed by OCT
As the case with IB-IVUS, OCT identiﬁed a more non-
omogeneous neointima in DES-ISR as compared to BMS-ISR,
specially with regard to late restenosis. More speciﬁcally, a non-
omogeneous pattern, low backscatter, and lipid-laden neointima
as more frequently observed in late DES restenosis as com-
ared to the BMS equivalent (45% vs. 80%, p<0.01; 51.7% vs. 85%,
< 0.01; 33.3% vs. 65% p=0.01, respectively). Visible microves-
els and lipid-laden neointima were seen more frequently in
arly DES restenosis as compared to early BMS restenosis (0%
s. 56%, p<0.01, 0% vs. 24%, p=0.04) (Table 3). Visible microves-
els and lipid-laden intima neointima were also more commonly
bserved in late BMS restenosis as compared to early BMS resteno-
is. Overall, visible microvessels were more frequently observed in
able 3
CT qualitative assessment (early phase <12 months or late phase ≥12 months).
BMS group (75 cross-sections) DES gr
Early (15
cross-
sections)
Late (60
cross-
sections)
p-Value* Early (
cross-
section
Tissue coverage structure
Homogeneous, n (%) 9 (60) 33 (55) 0.72 9 (36
Non-homogeneous, n (%) 6 (40) 27 (45) 16 (64
Heterogeneous, n (%) 1 (6.7) 13 (21.7) 13 (52
Layered, n (%) 5 (33.3) 14 (23.3) 3 (12
Backscatter
High, n (%) 7 (46.6) 29 (48.3) 0.55 12 (48
Low, n (%) 8 (53.3) 31 (51.7) 13 (52
Lumen shape
Regular, n (%) 10 (66.7) 51 (85) 0.10 22 (88
Irregular, n (%) 5 (33.3) 9 (15) 3 (12
Intra-luminal material
Microvessels, n (%) 0 26 (57.8) <0.01 14 (56
Lipid-laden neointima, n (%) 0 20 (33.3) <0.01 6 (24
TCFA neointima, n (%) 0 10 (16.7) 0.09 1 (4)
ata are presented as no. (%) or mean± SD.
CT, optical coherence tomography; BMS, bare metal stent; DES, drug-eluting stent; TCFA
-Value*: early phase vs. late phase in BMS. p-Value**: early phase vs. late phase in DES. pbetween the homogeneous and non-homogeneous patterns by integrated backscat-
ter intravascular ultrasound.
the non-homogeneous group by IB-IVUS (28.3% in homogeneous
pattern vs. 60.0% in non-homogeneous pattern, p<0.01) (Fig. 3).
The intra-observer and inter-observer agreements for the ISR OCT
signal pattern was within an acceptable range (intra-observer,
kappa=0.96; inter-observer, kappa=0.91, respectively).
Comparison between IB-IVUS and OCT ﬁndings
The pattern of ISR neointima (i.e. homogenous vs. non-
homogeneous) as identiﬁed by IB-IVUS was similar to that
identiﬁedbyOCT. Theoverall agreementbetween thepatternof ISR
neointima by IB-IVUS and that by OCT was excellent (kappa=0.85,
95% CI 0.76–0.94) (Table 4). In more detail, both IB-IVUS and OCT
identiﬁed a predominant non-homogeneous pattern in the ISR
neointima of DES restenosis, whereas the ISR neointima of BMS
restenosis was characterized by a homogeneous pattern accord-
ing to both IB-IVUS and OCT. Moreover, regarding the detection of
TCFA, the agreement between IB-IVUS-derived TCFA [7.5% (9/120)]
oup (45 cross-sections) p-Value† (Early
restenosis BMS vs.
DES)
p-Value‡ (Late
restenosis BMS vs.
DES)
25
s)
Late (20
cross-
sections)
p-Value**
) 4 (20) 0.24 0.14 <0.01
) 16 (80)
) 5 (25)
) 11 (55)
) 3 (15) 0.02 0.93 <0.01
) 17 (85)
) 20 (100) 0.10 0.10 0.07
) 0
) 13 (65) 0.54 <0.01 0.10
) 13 (65) <0.01 0.04 0.01
4 (20) 0.08 0.32 0.73
, thin-cap ﬁbroatheroma.
-Value†: BMS vs. DES in early phase. p-Value‡: BMS vs. DES in late phase.
K. Sato et al. / Journal of Cardiology 64 (2014) 488–495 493
Table 4
Comparison between IB-IVUS classiﬁcation and OCT classiﬁcation.
Early phase (<12months) Late phase (≥12months)
BMS (15 cross-sections) DES (25 cross-sections) BMS (60 cross-sections) DES (20 cross-sections)
IB-IVUS OCT IB-IVUS OCT IB-IVUS OCT IB-IVUS OCT
Homogeneous pattern, n (%) 10(66.7) 9 (60) 9(36) 9 (36) 37(61.7) 33 (55) 4(20) 4 (20)
Non-homogeneous pattern, n (%) 5(33.3) 6 (40) 16(64) 16 (64) 23(38.3) 27 (45) 16(80) 16 (80)
OCT classiﬁcationa
Homogeneous pattern (55 cross-sections) Non-homogeneous pattern (65 cross-sections) Total
IB-IVUS classiﬁcation
Homogeneous pattern (60 cross-sections) 53 7 60
Non-homogeneous pattern (60 cross-sections) 2 58 60
Total 55 65 120
Data are presented as no. (%).
IB-IVUS, integrated backscatter intravascular ultrasound; OCT, optical coherence tomography; BMS, bare metal stent; DES, drug-eluting stent.
a Cohen’s kappa=0.85 (95% CI 0.75–0.94).
Table 5
Comparison between IB-IVUS-derived TCFA and OCT-derived TCFA.
OCT-derived TCFA+ (15 cross-sections)a OCT-derived TCFA− (105 cross-sections)a Total
IB-IVUS-derived TCFA+ (9 cross-sections) 8 1 9
IB-IVUS-derived TCFA− (111 cross-sections) 7 104 111
Total 15 105 120
I ma; O
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cB-IVUS, integrated backscatter intravascular ultrasound; TCFA, thin cap ﬁbroathero
a Cohen’s kappa=0.63 (95% CI 0.39–0.88).
nd OCT-derived TCFA [12.5% (15/120)] was good (kappa=0.63,
5%CI 0.39–0.88) (Table 5).
rocedure outcomes
The slow ﬂow (SF) phenomenon occurred in ﬁve lesions [BMS
s. DES: 11.1% (1/15) vs. 44.4% (4/9)]. Moreover, this phenomenon
ccurred more frequently at MSA sites with a non-homogeneous
attern [homogeneous pattern by IB-IVUS vs. non-homogeneous
attern by IB-IVUS: 0% (0/9) vs. 33.3% (5/15), p=0.02]. Percentage
ipid neointima by IB-IVUS was greater in the non-homogeneous
han in the homogeneous pattern (38.0±13.0% vs. 27.3±12.3%,
< 0.01). Recurrent ISR occurred in six lesions [BMS vs. DES: 22.2%
2/15) vs. 44.4% (4/9)]with all of these lesions demonstrating anon-
omogeneous pattern at the MSA site [homogeneous pattern by
B-IVUS vs. non-homogeneous pattern by IB-IVUS: 0% (0/9) vs.
0.0% (6/15), p<0.01].
iscussion
This study aimed to qualitatively evaluate ISR neointima by IB-
VUS and examine how this evaluation compares to OCT. Ourmajor
ndings are:
1) The evaluation of neointima morphology by IB-IVUS revealed
similar ﬁndings as that by OCT.
2) The neointima of late DES restenosis, in contrast to that of late
BMS restenosis is characterized by a non-homogeneous pattern
according to both IB-IVUS and OCT.
Previous OCT studies have suggested that neoatherosclerosis
ncluding the presence of a lipid-laden neointima is more fre-
uently detected in DES late restenosis as compared to the BMS
quivalent [6,18,19]. Furthermore, histological studies have sug-
ested that in a signiﬁcant proportion of DES, neoatherosclerotic
hanges can be seen as early as 9 months after implantation,CT, optical coherence tomography.
whereas in BMS this process tends to be less aggressive and to occur
much later [20]. The atherosclerotic progression may be related
to dysfunctional endothelium leading to neointimal rupture and
very late stent thrombosis (VLST), which occursmore frequently in
DES as compared to BMS [20,21]. Similar results were observed in
our study where a predominant non-homogeneous neointima was
identiﬁed in lateDES restenosis. This is suggestive of a predominant
neoatherosclerotic process in late DES restenosis. In contrast, late
BMS restenosis was characterized by a pattern suggestive of both
neointimal hyperplasia and neoatherosclerosis. The relatively high
prevalence of non-homogeneous tissue restenosis that we found
in DES and the very low occurrence of VLST suggest that other
unknown factors come into play.
Comparison with previous studies utilizing IB-IVUS
Muraoka et al. [22] have reported a subgroup of DES resteno-
sis with low backscatter value (allegedly-corresponding to lipid) in
which distal SF was observed after balloon angioplasty (POBA). In
our study, SF occurred more frequently at MSA sites with a non-
homogeneous pattern where the percentage lipid neointima was
found to be greater as compared to sites with a homogeneous
pattern. Thus, the results of our study are in agreement with the
ﬁndings of the aforementioned study.
Comparison with previous study utilizing virtual histology-IVUS
In our study, the percentage lipid neointima in late phase
restenosis was higher than that in early phase restenosis
(BMS: 35.8±14.0% vs. 28.5±9.7%, p=0.06; DES: 37.0±13.9% vs.
24.1±10.7%, p<0.01). Percentage calciﬁcation in late restenosis
was also signiﬁcantly greater than that in early restenosis, again
in both stent types (BMS: 3.5±3.3% vs. 0.8±0.9%, p<0.01; DES:
0.9±0.4% vs. 0.5±0.3%, p<0.01). Although the absence of a clear
deﬁnition for necrotic core by IB-IVUS makes it extremely difﬁ-
cult to compare these observations to those obtained by virtual
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istology (VH)-IVUS, our results seem to be in agreement with
he VH-IVUS study of Kang et al. [23], who demonstrated that
MS- andDES-treated lesions can subsequentlydevelopan in-stent
ecrotic core and dense calcium, both of which are suggestive of
eoatherosclerosis.
omparison with previous study utilizing iMAP
Tsujita et al. [24] reported that DES implantation can be associ-
ted withmore iMAP-derived necrotic and less-ﬁbrotic neointimal
ormation compared with BMS implantation. In our study, how-
ver, there was no signiﬁcant difference between percentage lipid
nd ﬁbrous neointima in DES restenosis as compared to BMS
estenosis. These ﬁndings are consistentwith the results of IB-IVUS
nalysis by Muraoka et al. [22]. The discrepancy between the two
odalities could be related to differences in deﬁnitions for tissue
haracterization.
In our study, although OCT provided a detailed evaluation
f the neointima in ISR lesions, IB-IVUS gave a similar accurate
ssessment of neointima morphology. The two modalities agreed
egarding the pattern of restenosis in BMS and DES irrespective
f the timing. These ﬁndings suggest that IB-IVUS can be used
o evaluate neointimal morphology especially in situations where
ontrast volumeneeds to be kept at aminimumorwhen the assess-
ent of vessel size is important. It may also be a useful tool for
tratifying the risk of developing SF after plain-old balloon angio-
lasty as well as recurrent ISR by detecting a non-homogeneous
attern. Our results will need to be validated by a speciﬁc histolog-
cal study.
onclusion
This study indicates that the use of IB-IVUS in patients with sta-
le angina can provide similar information regarding the pattern of
SR neointima as the gold-standard OCT. Bothmodalities suggested
hat late DES restenosis is characterized by a non-homogeneous
ipid neointima as compared to that observed in the BMS equiva-
ent, which could be one of the reasons behind the VLST observed
ith DES. Larger studies are required to validate these ﬁndings.
imitations
This studywasa single-center investigationbasedona relatively
mall sample size. The use of native atherosclerosis criteria for the
haracterization of ISR neointimamay lead to signiﬁcantmisclassi-
cation as the color-coded classiﬁcation of IB-IVUS is based on the
istology of native coronary plaques. Moreover, we excluded acute
oronary syndrome patients in whom ISR neointima is more likely
o include TCFA and thrombus [25]. We cannot therefore conclude
hat IB-IVUS can provide similar detailed information regarding the
SR neointima pattern in these patients. A validation study compar-
ng the histology of ISR neointima and IB-IVUS ﬁndings is needed
n the future. We could not directly compare the differences at the
ame time interval after implantation between the neointima of
ate BMS and late DES restenosis because of the differences in the
ime-periods that these were identiﬁed. Finally, we cannot com-
ent on the natural history of neointima progression as serial
tudies of the same implanted stent were not performed and we
annot conclusively state that neointima composition plays a role
n determining clinical events.ource of funding
None.
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